Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

129 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses.
Ralston R, Thudium K, Berger K, Kuo C, Gervase B, Hall J, Selby M, Kuo G, Houghton M, Choo QL. Ralston R, et al. J Virol. 1993 Nov;67(11):6753-61. doi: 10.1128/JVI.67.11.6753-6761.1993. J Virol. 1993. PMID: 8411378 Free PMC article.
Further studies, to be reported separately, demonstrated that purified E1-E2 complexes were recognized at high frequency by HCV+ human sera (D. Y. Chien, Q.-L. Choo, R. Ralston, R. Spaete, M. Tong, M. Houghton, and G. Kuo, Lancet, in press) and generated prot …
Further studies, to be reported separately, demonstrated that purified E1-E2 complexes were recognized at high frequency by HCV+ human sera …
Vaccination of chimpanzees against infection by the hepatitis C virus.
Choo QL, Kuo G, Ralston R, Weiner A, Chien D, Van Nest G, Han J, Berger K, Thudium K, Kuo C, et al. Choo QL, et al. Among authors: ralston r. Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1294-8. doi: 10.1073/pnas.91.4.1294. Proc Natl Acad Sci U S A. 1994. PMID: 7509068 Free PMC article.
Preclinical characterization of the antiviral activity of SCH 900518 (narlaprevir), a novel mechanism-based inhibitor of hepatitis C virus NS3 protease.
Tong X, Arasappan A, Bennett F, Chase R, Feld B, Guo Z, Hart A, Madison V, Malcolm B, Pichardo J, Prongay A, Ralston R, Skelton A, Xia E, Zhang R, Njoroge FG. Tong X, et al. Among authors: ralston r. Antimicrob Agents Chemother. 2010 Jun;54(6):2365-70. doi: 10.1128/AAC.00135-10. Epub 2010 Mar 22. Antimicrob Agents Chemother. 2010. PMID: 20308381 Free PMC article.
Prospects for prophylactic and therapeutic hepatitis C virus vaccines.
Houghton M, Choo QL, Kuo G, Weiner A, Chien D, Ralston R, Urdea M, Moss B, Purcell R, Cummins L, et al. Houghton M, et al. Among authors: ralston r. Princess Takamatsu Symp. 1995;25:237-43. Princess Takamatsu Symp. 1995. PMID: 8875629 Review. No abstract available.
129 results